China National Accord Medicines Corporation Ltd.
Semi-Annual Report 2022
August 2022
Section I. Important Notice, Contents and Interpretation
Board of Directors, Supervisory Committee, all directors, supervisors and senior
executives of China National Accord Medicines Corporation Ltd. (hereinafter
referred to as the Company) hereby confirm that there are no any fictitious
statements, misleading statements, or important omissions carried in this report,
and shall take all responsibilities, individual and/or joint, for the reality,
accuracy and completion of the whole contents.
Lin Zhaoxiong, Principal of the Company, Gu Guolin, person in charger of
accounting works and Wang Ying, person in charge of accounting organ
(accounting principal) hereby confirm that the Financial Report of Semi-
Annual Report 2022 is authentic, accurate and complete.
All directors are attended the Board Meeting for report deliberation.
Contents
Section I. Important Notice, Contents and Interpretation ......1
Section II Company Profile and Main Financial Indexes......4
Section III Management Discussion and Analysis ......8
Section IV Corporate Governance......34
Section V Environmental and Social Responsibility......35
Section VI. Important Events ...... 39
Section VII. Changes in Shares and Particulars about Shareholders...... 79
Section VIII. Preferred Stock ......85
Section IX. Corporate Bonds ......86
Section X. Financial Report ...... 87
Documents Available for Reference
I.The financial statements carried with the signature and seals of legal representative, person in charger of accounting works and
person in charge of accounting organ;
II.Original text of all documents of the Company as well as the manuscript of the announcement disclosed in the reporting period on
Juchao Website.
III. Text of the Semi-Annual Report 2022 bearing the signature of the legal representative.
Interpretation
Items Refers to Contents
Listed Company, Company, the China National Accord Medicines
Company, Sinopharm Accord, the Group Refers to Corporation Ltd.
China National Pharmaceutical Group
SINOPHARM Refers to Corporation
Sinopharm Group Co., Ltd.; controlling
Sinopharm Holding Refers to shareholder of the Company
Company Law Refers to Company Law of the People’s Republic
of China
Securities Law Refers to Securities Law of the People’s Republic
of China
Yuan, 10 thousand Yuan, 100 million RMB, RMB 10 thousand, RMB 100
Yuan Refers to million
Abbreviation of the enterprises Refers to
Sinopharm Holding Guangzhou Refers to Sinopharm Holding Guangzhou Co., Ltd.
Guoda Drugstore Sinopharm Holding Guoda Drugstore
Refers to Co., Ltd.
Sinopharm Holding Guangxi Refers to Sinopharm Holding Guangxi Co., Ltd.
China National Zhijun (Shenzhen)
China National Zhijun Refers to Pharmaceutical Co., Ltd.
Zhijun Pharmacy Trade Shenzhen Zhijun Pharmacy Trade Co.,
Refers to Ltd.
China National Zhijun (Shenzhen)
Zhijun Pingshan Refers to Pingshan Pharmaceutical Co., Ltd.
Main Luck Pharmaceuticals Shenzhen Main Luck Pharmaceuticals
Refers to Inc.
Section II Company Profile and Main Financial Indexes
I. Company profile
Short form of the stock Sinopharm Accord, Accord B Stock code 000028, 200028
Stock exchange for listing Shenzhen Stock Exchange
Name of the Company (in
Chinese) 国药集团一致药业股份有限公司
Short form of the Company
(in Chinese if applicable) 国药一致
Foreign name of the
Company (if applicable) China National Accord Medicines Corporation Ltd.
Short
查看PDF原文
